CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net income	$ 5,716	$ 54,281
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	22,095	16,781
Amortization of deferred financing costs	799	399
Amortization of debt fair value adjustment	463	(28)
Amortization of restricted stock and restricted stock units	4,076	3,183
Equity in earnings of unconsolidated joint ventures	(1,705)	(1,315)
Equity in earnings from sale of unconsolidated joint venture properties	(14,744)	(64,531)
Gain on sale of real estate	(604)	(6)
Gain on insurance recovery	(240)	(62)
Loss on extinguishment of debt	0	563
Increases and decreases from changes in other assets and liabilities:
(Increase) decrease in other assets	(3,823)	1,820
Increase (decrease) in accounts payable and accrued liabilities	1,575	(2,635)
Net cash provided by operating activities	13,608	8,450
Cash flows from investing activities:
Improvements to real estate properties	(7,406)	(4,151)
Purchase of investment in joint ventures	0	(105,262)
Proceeds from the sale of real estate	711	4,385
Distributions from unconsolidated joint ventures	24,646	89,476
Contributions to unconsolidated joint ventures	(122)	(3,500)
Proceeds from insurance recoveries	240	62
Net cash provided by (used in) investing activities	18,069	(18,990)
Cash flows from financing activities:
Proceeds from mortgages payable	21,173	18,953
Mortgage payoffs	0	(26,761)
Mortgage principal payments	(2,435)	(1,475)
Proceeds from credit facility	0	22,000
Repayment of credit facility	(19,000)	(15,000)
Increase in deferred financing costs	(683)	(672)
Dividends paid	(14,251)	(13,136)
Distributions to non-controlling interests	(79)	(119)
Proceeds from the sale of common stock	0	9,945
Proceeds from issuance of DRIP shares	2,117	622
Repurchase of shares of common stock	(10,786)	0
Net cash used in financing activities	(23,944)	(5,643)
Net increase in cash, cash equivalents and restricted cash:	7,733	(16,184)
Cash, cash equivalents and restricted cash at beginning of period	21,153	38,921
Cash, cash equivalents and restricted cash at end of period	28,886	22,737
Supplemental disclosure of cash flow information:
Cash paid during the period for interest	15,310	9,169
Cash paid for income taxes	710	291
Consolidation on buyout of partnership interests:
Increase in real estate assets	0	(370,513)
Increase in other assets	0	(17,489)
Increase in mortgage payable	0	231,896
Increase in deferred loan costs	0	(3,892)
Increase in accounts payable and accrued liabilities	0	6,278
Decrease in investment in unconsolidated joint ventures	0	48,458
Purchase and consolidation of investment in joint venture	0	(105,262)
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows.
Cash and cash equivalents	28,117	21,865
Restricted cash	769	872
Total cash, cash equivalents and restricted cash, shown in consolidated statement of cash flows	$ 28,886	$ 22,737